適當(dāng)?shù)目笴D 2抗體對將刺激外周T細(xì)胞增殖和效應(yīng)子功能。CD 2分子已被證明是白細(xì)胞功能抗原(LFA-3/CD 58)的受體,其結(jié)合增強(qiáng)由T細(xì)胞抗原受體(TCR)介導(dǎo)的T細(xì)胞活化。抗人CD 2可用于通過補(bǔ)體介導(dǎo)的細(xì)胞毒性消耗CD 2陽性細(xì)胞。使用抗CD 2抗體進(jìn)行NK淋巴細(xì)胞亞群的分析和T細(xì)胞來源的淋巴瘤和白血病的鑒定。 抗人CD2(G11)抗體原液該產(chǎn)品同種型對照:Mouse IgG2a In Vivo Isotype Control - Low Endotoxin [C1.18.4] (ICH2245) 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.